Malcolm Salter, Director at C4 Therapeutics, Inc. (CCCC), sold 755 shares at $49.89 ($38K) on 2021-09-17, disclosed to the SEC on 2021-09-21.
Scheduled sale ($38k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CCCC | SELL | 2021-10-15 | $34K | — | Filing → |
| CCCC | SELL | 2021-08-24 | $31K | — | Filing → |
| CCCC | SELL | 2021-07-19 | $28K | — | Filing → |